Pharmafile Logo
Pharmafocus logo
Advanced Search

Biogen IDEC

Showing 5 posts of 20 posts found.

biogen idec image

Biogen signs neurology deal

September 11, 2013
Research and Development, Sales and Marketing Biogen IDEC, Isis, antisense, neurology

Biogen Idec and Isis Pharmaceuticals have entered their fourth partnership in two years in a deal that will see the …

News
biogen idec image

Multiple sclerosis rivals gain EU approval

March 27, 2013
Research and Development, Sales and Marketing Biogen IDEC, Genzyme, MS

Rival MS treatments from Biogen Idec and Genzyme have both received European approval. The CHMP has recommended marketing authorisation for …

News
Tysabri image

Biogen and Elan file for Tysabri first line use in MS

January 18, 2013
Sales and Marketing Biogen IDEC, EMA, Elan, FDA, MS, Tsyabri, gilenya

Biogen Idec and Elan have applied to the FDA and EMA to expand Tysabri’s use in patients with relapsing forms …

News

Biogen Idec appoints new head of R&D

January 6, 2011
Research and Development, Sales and Marketing Biogen IDEC, Douglas Williams, Steven Holtzman, appointment, research and development, sales and marketing

Biogen Idec has a new head of research and development, appointing Douglas Williams to oversee its global operations. The position …

Appointment

Biogen Idec buys neurodegenerative disease rights

December 21, 2010
Research and Development Alzheimer's, Alzheimer's disease, Alzheimer’s, Alzheimer’s disease, Biogen, Biogen IDEC, Neurimmune, Parkinson's disease, Parkinson’s disease, amyotrophic lateral sclerosis, neurodegenerative diseases

Biogen Idec has acquired a subsidiary of Swiss biotech company Neurimmune, and the rights to three pre-clinical immunotherapy drugs. The …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026